RESULTS OF TREATMENT MANAGEMENT OF RIFAMPICIN-RESISTANT TUBERCULOSIS IN THAI NGUYEN PERIOD 2016-2020 AND SOME RELATED FACTORS
Main Article Content
Abstract
Objectives: To describe the results of treatment management of rifampicin-resistant tuberculosis in Thai Nguyen period 2016-2020 and some related factors. Research Method: A cross-sectional descriptive study was conducted on 92 rifampicin-resistant patients in the period 2016-2020 at Thai Nguyen Tuberculosis and Lung Disease Hospital. Results: The mean age of rifampicin-resistant patients was 40.9±12.3, the male proportion was 79.3%. The proportion of TB retreatment was 73.9%, new cases 26.1% and HIV(+) 19.6%. The proportion of lung TB was 97.8%; AFB(+) 72.8%. The proportion of testing adherence during treatment follow-up was 28.3%. The proportion of cure 3.5%, treatment completed 75.5%, death 10.5%, failure 2.3%, dropout 7.0%, transferred out 1.2%. There were relationship between: poor household economic status, TB retreatment, comorbidities, HIV(+), AFB(+), 20 months treatment duration, patients in prison, non-testing adherence and had adverse drug reaction with unsuccessful treatment of rifampicin-resistant (p<0.05). Conclusion: The proportion of RR-TB successful treatment in Thai Nguyen is relatively high, the retreatment and disease characteristics factors are related to unsuccessful treatment.
Article Details
Keywords
Treatment management, Rifampicin-resistance tuberculosis, Thai Nguyen
References
2. Bộ Y tế (2020), Cập nhật hướng dẫn chẩn đoán điều trị và dự phòng bệnh lao, Nhà xuất bản Y học, Hà Nội.
3. Bulabula A.N.H., Nelson J.A., Musafiri E.M., et al. (2019), "Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study", Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 69 (8), pp. 1278-1287.
4. Katende B., Esterhuizen T.M., Dippenaar A., et al. (2020), "Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes", Sci Rep, 10 (1), pp. 1917.
5. Phuong N.T.M., Nhung N.V., Hoa N.B., et al. (2016), "Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam", Public health action, 6 (1), pp. 25-31.
6. Van Le Hong, Phu Phan Trieu, Vinh Dao Nguyen, et al. (2020), "Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study", BMC Infectious Diseases, 20 (1), pp. 164.
7. World Health Organization (2020), Global tuberculosis report 2020, World Health Organization, Geneva, Switzerland.